Decreased TCF7L2 protein levels in T2DM are also correlated with downregulated Gastric Inhibitory Polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors and impaired beta-cell function10. Here, TCF7L2 is linked to type 2 diabetes mellitus.